Free shipping on all orders over $ 500

Linperlisib (YY-20394)

Cat. No. M10443
Linperlisib (YY-20394) Structure
Synonym:

YY-20394; PI3Kδ-IN-2

Size Price Availability Quantity
5mg USD 80  USD80 In stock
10mg USD 130  USD130 In stock
25mg USD 280  USD280 In stock
50mg USD 440  USD440 In stock
100mg USD 700  USD700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Linperlisib, also known as YY-20394 and PI3Kδ-IN-2, is a potent and selective PI3Kδ inhibitor. Linperlisib significantly inhibited T cell differentiation into Treg both in mouse splenocyte and in human primary CD4+ T cells, and was especially potent inhibiting their IL-10 secretion in vitro. YY-20394 significantly inhibited primary tumor growth in immune-competent mice with 4T1 and CT26 tumors, as well as 4T1 lung metastasis with dose dependency.

Chemical Information
Molecular Weight 588.69
Formula C28H37FN6O5S
CAS Number 1702816-75-8
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Bo Jiang, et al. J Hematol Oncol. Ρhаse 1 cliпιcаl tгιal of the PI3Kδ inhibitor YY-20394 in ρаtιепts with B-cell hematological malignancies

Related PI3K Products
SNV4818

SNV4818 is a potential best-in-class (best-in-class) mutation-selective PI3K-α inhibitor with excellent selectivity for the H1047X mutant and moderate selectivity for the related E545/542X mutant.

hSMG-1 inhibitor 11j

hSMG-1 inhibitor 11j, a pyrimidine derivative, is a potent and selective inhibitor of hSMG-1, with an IC50 of 0.11 nM.

RLY-2608

RLY-2608 is a first-in-class, orally active, selective inhibitor of PI3Ka metabolism.

EDI048

EDI048 is an orally active Cryptosporidium PI4K inhibitor for the research of cryptosporidiosis.

PI3Kδ-IN-13

PI3Kδ-IN-13 is a PI3Kδ inhibitor (IC50=2.6 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: Linperlisib (YY-20394), YY-20394; PI3Kδ-IN-2 supplier, PI3K, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.